22 May 2019
Why you should treat your PCI patients with the COMBO Plus stent – Insight from clinical-based evidence
Sponsored by OrbusNeich
Chairpersons:
M. Haude, D. Weilenmann
Summary
Consult this session to learn how COMBO Plus stent's unique design meets your clinical requirements, in all comers and high risk populations (ACS, Left Main PCI, etc.).
Learning Objectives
- To learn how COMBO's unique design meets your clinical requirements
- To hear about the clinical evidence with COMBO in all comers and high risk populations
- To understand the COMBO clinical evidence supporting tailored DAPT strategies
